Tower Research Capital LLC (Trc) Landec Corp \Ca\ Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Landec Corp \Ca\ stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,261 shares of LNDC stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,261Holding current value
$0% of portfolio
0.0%Shares
26 transactions
Others Institutions Holding LNDC
# of Institutions
80Shares Held
20.5MCall Options Held
65.8KPut Options Held
14.1K-
Wynnefield Capital Inc New York, NY4.92MShares$00.0% of portfolio
-
Legion Partners Asset Management, LLC Los Angeles, CA2.97MShares$00.0% of portfolio
-
Greenhaven Road Investment Management, L.P. Greenwich, CT2.23MShares$00.0% of portfolio
-
22 Nw, LP Seattle, WA1.76MShares$00.0% of portfolio
-
Black Rock Inc. New York, NY1.45MShares$00.0% of portfolio
About LANDEC CORP \CA\
- Ticker LNDC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 29,595,600
- Description
- Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...